Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 8, 2013, Pages 1615-1620

  Milojevic, Bogomir ^a   Djokic, Milan ^a   Sipetic Grujicic, Sandra ^a   Grozdic Milojevic, Isidora ^b   Vuksanovic, Aleksandar ^a   Nikic, Predrag ^a   Vukovic, Ivan ^a   Djordjevic, Dejan ^a   Bumbasirevic, Uros ^a   Tulic, Cane ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Non muscle invasive bladder tumor history; Recurrence; Survival; Upper urinary tract urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CLINICAL EVALUATION; DISTANT METASTASIS; FEMALE; HUMAN; KAPLAN MEIER METHOD; KIDNEY PELVIS TUMOR; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROURETERECTOMY; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SURVIVAL RATE; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA; TUMOR LOCALIZATION; URETER TUMOR;

NON-MUSCLE-INVASIVE BLADDER TUMOR HISTORY; RECURRENCE; SURVIVAL; UPPER URINARY TRACT UROTHELIAL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; URETER; URINARY BLADDER NEOPLASMS; URINARY TRACT; UROLOGIC NEOPLASMS;

EID: 84886249062     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.03.004     Document Type: Article

References (26)

1. Jamal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 2006, 2006:106-130.
2. Hall M.C., Womack S., Sagalowsky A.I., et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 1998, 52:594-601.
3. Roscigno M., Cozzarini C., Bertini R., et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008, 53:794-802.
4. Raman J.D., Ng C.K., Scherr D.S., et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010, 57:1072-1079.
5. Kikuchi E., Margulis V., Karakiewicz P.I., et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009, 27:612-618.
6. Favaretto R.L., Shariat S.F., Chade D.C., et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010, 58:574-580.
7. Akdogan B., Dogan H.S., Eskicorapci S.Y., et al. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006, 176:48-52.
8. Mullerad M., Russo P., Golijanin D., et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004, 172:2177-2181.
9. Fleming I.D., Cooper J.S., Henson D.E., et al. Genitourinary site. AJCC Cancer Staging Manual 1997, 231-246. Lippincott-Raven, Philadelphia. 5th ed. R. Touhey (Ed.).
10. Epstein J.I., Amin M.B., Reuter V.R., et al. The World Health Organization/International Society of Urological pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-1448.
11. Dragicevic D., Djokic M., Pekmezovic T., et al. Survival of patients with transitional cell carcinoma of the ureter and RAL pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. BJU Int 2007, 99:1357-1362.
12. Djokic M., Hadzi-Djokic J., Nikolic J., et al. Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia. Prog Urol 1999, 9:61-68.
13. Miyake H., Hara I., Arakawa S., et al. A clinicopathologic study of bladder cancer associated with upper urinary tract cancer. BJU Int 2000, 85:37-41.
14. Youssef R.F., Shariat S.F., Lotan Y., et al. Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology 2011, 77:861-866.
15. Pasin E., Josephson D.Y., Mitra A.P., et al. Superficial bladder cancer: An update on etiology, molecular development, classification, and natural history. Rev Urol 2008, 10:31-43.
16. Chade D.C., Shariat S.F., Adamy A., et al. Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol 2010, 184:464-469.
17. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 2007, 51:152-160.
18. Matsui Y., Utsunomiya N., Ichioka K., et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005, 65:279-283.
19. Milojevic B., Djokic M., Sipetic-Grujicic S., et al. Bladder cancer after managing upper urinary tract transitional cell carcinoma: Risk factors and survival. Int Urol Nephrol 2011, 43:729-735.
20. Chromecki T.F., Cha E.K., Fajkovic H., et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 2012, 61:245-253.
21. Raman J.D., Ng C.K., Scherr D.S., et al. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010, 57:1072-1079.
22. Margulis V., Shariat S.F., Matin S.F., et al. Outcomes of radical nephroureterectomy: A series from the upper tract urothelial carcinoma collaboration. Cancer 2009, 115:1224-1233.
23. Milojevic B., Djokic M., Sipetic-Grujicic S., et al. Upper urinary tract transitional cell carcinoma: Location is not correlated with prognosis. BJU Int 2012, 109:1037-1042.
24. Vukelić M., Sostarić B., Belicza M. Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 1992, 30:193-200.
25. Cukuranovic R., Ignjatovic M., Stefanovic V., et al. Urinary tract tumors and Balkan nephropathy in south Morava river basin. Kidney Int 1991, 40(Suppl 34):80-84.
26. Dragicevic D., Djokic M., Pekmezovic T., et al. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma. Urol Int 2009, 82:335-340.